期刊文献+

新专利法实施后药品“强制许可”大有可为

The "Compulsory Licenses" Will be Powerful after the Implementation of the New Drug Patent Law
原文传递
导出
摘要 从专利制度建立以来,专利权和公共健康权之问的斗争就没有停止过。不断完善的药品专利强制许可制度是解决药品专利保护与公共健康之间矛盾的一种平衡措施。新修订的《中华人民共和国专利法》打开了我国药品进出口的“强制许可”大门,作为一个负责任的最大的发展中国家,中国在保护全人类的公众健康方面应该大有可为。由于强制许可也存在诸多负面效应,所以使用时要适可而止。 Since the establishment of the patent system, the battle between patent right and public health right has never stopped. Constantly improvement of drug compulsory license system is a balance measures to resolve the conflict between drug patent protection and public health. Recently, the "The People's Republic of China Patent Law" opens a door for export of " drugs compulsory license". As a responsible country and the largest developing country, China can do more things in protecting the public health of all mankind. Because there are many negative effects of compulsory license, the use of comoulsorv license should be controlled approoriatelv.
作者 郎跃武 李菊
出处 《科技成果管理与研究》 2009年第11期17-19,共3页 Management And Research On Scientific & Technological Achievements
关键词 专利法 药品 强制许可 公共健康 patent Law drugs compulsory license public health
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部